According to a market report by Lucintel, the future of the neoantigen targeted therapy market in Germany looks promising with opportunities in the medical research institution and hospital & clinic markets. The neoantigen targeted therapy market in Germany is expected to reach an estimated $1641.7 billion by 2031 with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the growing occurrence of cancer and the progress in genomic sequencing technologies.
A more than 150-page report to understand trends, opportunity and forecast in neoantigen targeted therapy market in Germany to 2031 by type (monotherapy and combination therapy), target disease indication (colorectal cancer, renal cell carcinoma, non-small cell lung cancer, bone cancer, and gynecological cancer), immunotherapy type (DNA or RNA-based vaccines, protein-based vaccines, dendritic cell vaccines, and til-based therapies), and application (medical research institution, hospital & clinic, and others).
Download sample by clicking on neoantigen targeted therapy market in Germany
Lucintel forecasts that, within the immunotherapy type category, protein-based vaccines are expected to witness the highest growth over the forecast period.
Within the application category, hospitals & clinics are expected to witness the highest growth.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Neoantigen Targeted Therapy Market in Italy
Neoantigen Targeted Therapy Market in Netherlands
Neoantigen Targeted Therapy Market in Spain
Neoantigen Targeted Therapy Market in Turkey
Neoantigen Targeted Therapy Market in United Kingdom